Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
about
P1343
Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesisRole of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cellsNf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferaseEpidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal modelsSingle cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.A role for Pak protein kinases in Schwann cell transformation.MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumorsTargeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumorsInduction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors.
P2860
Q24550567-6B7CE2CD-B963-4E2B-9FD3-AF58515C6367Q28511967-F74EA852-5FEF-4F76-B134-F9D82EEE3CD2Q28588037-0DA225A9-DDDF-45BF-BAB5-4E7958049555Q30500853-DE21EC72-812B-41AC-B1E6-9073D63BBBB2Q34734319-5454371C-57FD-485C-ABF6-EE306C4A4A34Q35070041-4E3E69BE-FE34-4AAC-B541-4055A0FF4EFBQ36065075-E4980375-F530-4843-9EDB-E9C5C9F4D31EQ36127420-C4B2B67E-3BB0-447F-B273-CE3C93B10F8DQ37734257-B98A5FA1-6691-4990-8C26-90BEE09701D9Q38341928-A7DEA937-A322-4724-80CA-6EB241F51680Q39998302-313B9962-6C83-444A-BBCF-8DCA54B8FAB4Q48303412-4DCADC9B-F414-4E77-9B1C-C8EE2A92158F
P2860
Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Farnesyltransferase inhibitors ...... e I (NF1) malignant phenotype.
@en
type
label
Farnesyltransferase inhibitors ...... e I (NF1) malignant phenotype.
@en
prefLabel
Farnesyltransferase inhibitors ...... e I (NF1) malignant phenotype.
@en
P2093
P1433
P1476
Farnesyltransferase inhibitors ...... e I (NF1) malignant phenotype.
@en
P2093
P304
P407
P4510
P577
1995-08-01T00:00:00Z